News
Since the dawn of human spaceflight, scientists have carefully studied the effects of space and microgravity on astronauts.
In celebration of Ophthalmology Times ' 50th anniversary, we asked leading experts in the field, in a perfect world, if they ...
8d
TipRanks on MSNPYC Therapeutics Advances PYC-001 for Blinding Eye Disease
An update from PYC Therapeutics Limited ( ($AU:PYC) ) is now available. PYC Therapeutics Limited announced the completion of dosing in its Phase 1 ...
Attendance Allowance, a tax-free benefit administered by the Department for Work and Pensions ( DWP ), currently provides additional financial support to over 1.6 million people across Great Britain.
Stoke Therapeutics, Inc.'s zorevunersen shows promise in Dravet syndrome with FDA breakthrough designation. Click for my updated look at STOK stock.
Donruss Optic Basketball is making it's return yet again this year, giving collectors the chance to rip what is arguably one of the most anticipated Basketball products each calendar year. Optic is at ...
Patients with type 2 diabetes (T2D) on semaglutide or tirzepatide showed a higher incidence of nonarteritic anterior ischemic optic neuropathy and other optic nerve disorders compared to other ...
New research links two widely used diabetes drugs, semaglutide or tirzepatide, to a rare but potentially vision-threatening eye condition, raising questions about drug-specific risks and the need for ...
Autosomal dominant optic atrophy (ADOA), the most common genetic optic neuropathy, is an insidious disease. It often presents slowly during childhood by way of blurry vision, trouble reading or ...
1 National Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, Wenzhou, People's Republic of China 2 National Clinical Research Center for ...
A 38-year-old woman with trisomy 21 presented with unilateral optic nerve atrophy due to Moyamoya Disease (MMD). She had a narrow palate, epicanthal folds and moderate developmental delay. Her past ...
Alfredo Sadun, MD, PhD, details a fascinating outcome from a gene therapy in development for Leber hereditary optic neuropathy. During the recent Association for Research in Vision and Ophthalmology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results